Bausch + Lomb makes an acquisition to expand its glaucoma offerings; Roche gets a major approval in Europe for Vabysmo; and EssilorLuxottica buys a maker of noninvasive ophthalmic medical devices.  Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Bausch + Lomb makes an acquisition to expand its glaucoma offerings; Roche gets a major approval in Europe for Vabysmo; and EssilorLuxottica buys a maker of noninvasive ophthalmic medical devices. Learn more about your ad choices. Visit megaphone.fm/adchoices

Bausch + Lomb makes an acquisition to expand its glaucoma offerings; Roche gets a major approval in Europe for&nbsp;Vabysmo; and EssilorLuxottica buys a maker of noninvasive ophthalmic medical devices.&nbsp; Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices" rel="noopener noreferrer">megaphone.fm/adchoices</a>

B+L Bolsters Glaucoma Offerings with Elios Acquisition

Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

News

Business News

Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

Eyewire News:&nbsp;The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

Share B+L Bolsters Glaucoma Offerings with Elios Acquisition

Sign up to save your podcasts

B+L Bolsters Glaucoma Offerings with Elios Acquisition

B+L Bolsters Glaucoma Offerings with Elios Acquisition